Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Crowley

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|October 18, 2020
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic PlaqueGregg W Stone, Akiko Maehara, Ziad A Ali, et al.
European Heart Journal|November 12, 2019
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registriesShmuel Chen, Bjorn Redfors, Tamim Nazif, et al.
Circulation. Heart Failure|September 17, 2019
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 TrialsAriel Furer, Shmuel Chen, Bjorn Redfors, et al.
European Heart Journal|September 11, 2019
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trialTamim M Nazif, Shmuel Chen, Isaac George, et al.
Circulation|November 7, 2019
Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER TrialsMatthew R Summers, Martin B Leon, Craig R Smith, et al.
European Heart Journal|March 29, 2019
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trialOri Ben-Yehuda, Shmuel Chen, Björn Redfors, et al.
Minerva Cardiology and Angiology|December 1, 2020
Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trialsMahesh V Madhavan, Behnood Bikdeli, Björn Redfors, et al.
Journal of the American College of Cardiology|March 29, 2020
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary PlaquesMyong Hwa Yamamoto, Akiko Maehara, Gregg W Stone, et al.
Thrombosis and Haemostasis|December 11, 2019
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and MethodologyBehnood Bikdeli, Thomas McAndrew, Aaron Crowley, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2021
Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunctionStamatios Lerakis, Annapoorna S Kini, Federico M Asch, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|October 18, 2020
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic PlaqueGregg W Stone, Akiko Maehara, Ziad A Ali, et al.
European Heart Journal|November 12, 2019
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registriesShmuel Chen, Bjorn Redfors, Tamim Nazif, et al.
Circulation. Heart Failure|September 17, 2019
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 TrialsAriel Furer, Shmuel Chen, Bjorn Redfors, et al.
European Heart Journal|September 11, 2019
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trialTamim M Nazif, Shmuel Chen, Isaac George, et al.
Circulation|November 7, 2019
Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER TrialsMatthew R Summers, Martin B Leon, Craig R Smith, et al.
European Heart Journal|March 29, 2019
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trialOri Ben-Yehuda, Shmuel Chen, Björn Redfors, et al.
Minerva Cardiology and Angiology|December 1, 2020
Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trialsMahesh V Madhavan, Behnood Bikdeli, Björn Redfors, et al.
Journal of the American College of Cardiology|March 29, 2020
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary PlaquesMyong Hwa Yamamoto, Akiko Maehara, Gregg W Stone, et al.
Thrombosis and Haemostasis|December 11, 2019
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and MethodologyBehnood Bikdeli, Thomas McAndrew, Aaron Crowley, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2021
Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunctionStamatios Lerakis, Annapoorna S Kini, Federico M Asch, et al.
Pageof 7